FDA to review broader access to restricted peptides in July FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner FDA to Convene Pharmacy Compounding Advisory Committee in July Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA Peptide Reclassification 2026: What Researchers Want